The Hydration Pharmaceuticals Company Limited (ASX:HPC)
Australia · Delayed Price · Currency is AUD 0.0030
0.00 (0.00%)
Sep 1, 2026, 3:52 PM AEST
ASX:HPC Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2.15 | 2.47 | 3.2 | 4.3 | 9.1 | 6.13 | |
Revenue Growth | -26.62% | -22.88% | -25.48% | -52.74% | 48.52% | 63.10% |
Cost of Revenue | 1.12 | 1.11 | 1.58 | 2.4 | 4.4 | 3.34 |
Gross Profit | 1.03 | 1.36 | 1.62 | 1.9 | 4.7 | 2.79 |
Selling, General & Admin | 3.74 | 4.51 | 5.82 | 8.77 | 15.4 | 9.62 |
Operating Expenses | 3.74 | 4.51 | 5.82 | 8.77 | 15.4 | 9.62 |
Operating Income | -2.71 | -3.15 | -4.2 | -6.87 | -10.7 | -6.83 |
Interest Expense | -0 | -0 | -1.76 | -0.64 | -0.09 | -2.54 |
Currency Exchange Gain (Loss) | -0.01 | -0.01 | 0.4 | -0.01 | 0.12 | 1.41 |
Other Non Operating Income (Expenses) | 0.24 | 0.41 | -0.11 | 0.29 | 0.07 | 0 |
EBT Excluding Unusual Items | -2.48 | -2.75 | -5.67 | -7.23 | -10.61 | -7.97 |
Other Unusual Items | - | - | - | - | - | -0.99 |
Pretax Income | -2.48 | -2.75 | -5.67 | -7.23 | -10.61 | -8.95 |
Earnings From Continuing Operations | -2.48 | -2.75 | -5.67 | -7.23 | -10.61 | -8.95 |
Earnings From Discontinued Operations | -0 | -0.11 | 8.34 | -0.87 | - | - |
Net Income | -2.48 | -2.86 | 2.67 | -8.1 | -10.61 | -8.95 |
Net Income to Common | -2.48 | -2.86 | 2.67 | -8.1 | -10.61 | -8.95 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 436 | 387 | 291 | 195 | 163 | 76 |
Shares Outstanding (Diluted) | 436 | 387 | 373 | 195 | 163 | 76 |
Shares Change | 7.45% | 3.87% | 91.04% | 19.95% | 115.37% | 16.35% |
EPS (Basic) | -0.01 | -0.01 | 0.01 | -0.04 | -0.07 | -0.12 |
EPS (Diluted) | -0.01 | -0.01 | 0.01 | -0.04 | -0.07 | -0.12 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -2.97 | -3.65 | -3.88 | -5.73 | -9.75 | -8.08 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.03 | -0.06 | -0.11 |
Gross Margin | 47.72% | 55.18% | 50.58% | 44.18% | 51.61% | 45.53% |
Operating Margin | -126.14% | -127.29% | -130.95% | -159.62% | -117.60% | -111.52% |
Profit Margin | -115.36% | -115.75% | 83.23% | -188.39% | -116.56% | -146.10% |
Free Cash Flow Margin | -138.15% | -147.82% | -121.03% | -133.22% | -107.16% | -131.84% |
EBITDA | - | - | - | - | -10.7 | -6.83 |
EBITDA Margin | - | - | - | - | -117.57% | -111.47% |
D&A For EBITDA | - | - | - | - | 0 | 0 |
EBIT | -2.71 | -3.15 | -4.2 | -6.87 | -10.7 | -6.83 |
EBIT Margin | -126.14% | -127.29% | -130.95% | -159.62% | -117.60% | -111.52% |